AZULIX 1 MF (Glimepiride (1mg) + Metformin (500mg))

AZULIX MF 1MG TABLET is prescribed to individuals with type 2 diabetes mellitus when lifestyle modifications such as diet and exercise, along with monotherapy, do not provide sufficient glycemic control. This medication consists of a combination of Glimepiride and Metformin, both of which are classified as antidiabetic agents. Glimepiride works by stimulating the pancreas to release more insulin, enhancing the body’s ability to utilize insulin effectively. Meanwhile, Metformin helps lower the overall amount of glucose released into the bloodstream by the liver. For optimal results while taking AZULIX MF 1MG TABLET, it is essential to adhere to a consistent exercise regimen and dietary guidelines as recommended by a healthcare provider. Prior to starting this medication, it is important to inform your doctor if you have type 1 diabetes, diabetic ketoacidosis, severe liver or kidney impairment, or acute cardiovascular conditions. Additionally, notify your healthcare professional if you are pregnant or nursing. This medication is not approved for individuals under 18 years of age. It is advised to refrain from alcohol consumption while taking AZULIX MF 1MG TABLET, as it may alter the blood sugar-lowering effects and elevate the risk of lactic acidosis. Common adverse effects associated with this medication include disturbances in taste, gastrointestinal upset such as diarrhea, and abdominal discomfort. If any of these symptoms become severe or concerning, please reach out to your healthcare provider for further guidance.